Literature DB >> 20489079

Prostate MRI and 3D MR spectroscopy: how we do it.

Sadhna Verma1, Arumugam Rajesh, Jurgen J Fütterer, Baris Turkbey, Tom W J Scheenen, Yuxi Pang, Peter L Choyke, John Kurhanewicz.   

Abstract

OBJECTIVE: This review is a primer on the technical aspects of performing a high-quality MRI and MR spectroscopic imaging examination of the prostate.
CONCLUSION: MRI and MR spectroscopic imaging are useful tools in the localization, staging, and functional assessment of prostate cancer. Performing a high-quality MR spectroscopic examination requires understanding of the technical aspects and limitations of spectral acquisition, postprocessing techniques, and spectral evaluation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20489079      PMCID: PMC2895419          DOI: 10.2214/AJR.10.4312

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  33 in total

1.  Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate.

Authors:  Jurgen J Fütterer; Tom W J Scheenen; Stijn W T P J Heijmink; Henkjan J Huisman; Christina A Hulsbergen-Van de Kaa; J Alfred Witjes; Arend Heerschap; Jelle O Barentsz
Journal:  Invest Radiol       Date:  2007-02       Impact factor: 6.016

2.  High-speed 3T MR spectroscopic imaging of prostate with flyback echo-planar encoding.

Authors:  Albert P Chen; Charles H Cunningham; Esin Ozturk-Isik; Duan Xu; Ralph E Hurd; Douglas A C Kelley; John M Pauly; John Kurhanewicz; Sarah J Nelson; Daniel B Vigneron
Journal:  J Magn Reson Imaging       Date:  2007-06       Impact factor: 4.813

Review 3.  MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer.

Authors:  H Hricak
Journal:  Br J Radiol       Date:  2005       Impact factor: 3.039

4.  Optimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3T.

Authors:  Tom W J Scheenen; Giulio Gambarota; Elisabeth Weiland; Dennis W J Klomp; Jurgen J Fütterer; Jelle O Barentsz; Arend Heerschap
Journal:  Magn Reson Med       Date:  2005-06       Impact factor: 4.668

5.  Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T.

Authors:  Charles H Cunningham; Daniel B Vigneron; Malgorzata Marjanska; Albert P Chen; Duan Xu; Ralph E Hurd; John Kurhanewicz; Michael Garwood; John M Pauly
Journal:  Magn Reson Med       Date:  2005-05       Impact factor: 4.668

6.  Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system.

Authors:  Juyoung A Jung; Fergus V Coakley; Daniel B Vigneron; Mark G Swanson; Aliya Qayyum; Vivian Weinberg; Kirk D Jones; Peter R Carroll; John Kurhanewicz
Journal:  Radiology       Date:  2004-12       Impact factor: 11.105

7.  Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance.

Authors:  Stijn W T P J Heijmink; Jurgen J Fütterer; Thomas Hambrock; Satoru Takahashi; Tom W J Scheenen; Henkjan J Huisman; Christina A Hulsbergen-Van de Kaa; Ben C Knipscheer; Lambertus A L M Kiemeney; J Alfred Witjes; Jelle O Barentsz
Journal:  Radiology       Date:  2007-05-10       Impact factor: 11.105

Review 8.  Advances in MR spectroscopy of the prostate.

Authors:  John Kurhanewicz; Daniel B Vigneron
Journal:  Magn Reson Imaging Clin N Am       Date:  2008-11       Impact factor: 2.266

9.  Simultaneous in vivo spectral editing and water suppression.

Authors:  M Mescher; H Merkle; J Kirsch; M Garwood; R Gruetter
Journal:  NMR Biomed       Date:  1998-10       Impact factor: 4.044

10.  Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility.

Authors:  Tom W J Scheenen; Stijn W T P J Heijmink; Stefan A Roell; Christina A Hulsbergen-Van de Kaa; Ben C Knipscheer; J Alfred Witjes; Jelle O Barentsz; Arend Heerschap
Journal:  Radiology       Date:  2007-09-11       Impact factor: 11.105

View more
  20 in total

1.  Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer.

Authors:  Amita Shukla-Dave; Hedvig Hricak; Oguz Akin; Changhong Yu; Kristen L Zakian; Kazuma Udo; Peter T Scardino; James Eastham; Michael W Kattan
Journal:  BJU Int       Date:  2011-09-20       Impact factor: 5.588

2.  Investigation of the PSF-choice method for reduced lipid contamination in prostate MR spectroscopic imaging.

Authors:  Lawrence P Panych; Joseph R Roebuck; Nan-kuei Chen; Yi Tang; Bruno Madore; Clare M Tempany; Robert V Mulkern
Journal:  Magn Reson Med       Date:  2012-11       Impact factor: 4.668

3.  Magnetic resonance imaging for prostate cancer clinical application.

Authors:  Bing Li; Yong Du; Hanfeng Yang; Yayong Huang; Jun Meng; Dongmei Xiao
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

Review 4.  Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic Opportunities.

Authors:  Giorgia Zadra; Massimo Loda
Journal:  Cold Spring Harb Perspect Med       Date:  2018-10-01       Impact factor: 6.915

Review 5.  Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer?

Authors:  Roberto García-Figueiras; Sandra Baleato-González; Anwar R Padhani; Laura Oleaga; Joan C Vilanova; Antonio Luna; Juan Carlos Cobas Gómez
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

6.  [Diagnose importance of multiparametric magnetic resonance tomography for prostate cancer].

Authors:  B J Fueger; T H Helbich; M Schernthaner; S Zbýn; H G Linhart; A Stiglbauer; A Doan; K Pinker; G Heinz; A R Padhani; P Brader
Journal:  Radiologe       Date:  2011-11       Impact factor: 0.635

7.  Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values.

Authors:  Gregor Thörmer; Josephin Otto; Martin Reiss-Zimmermann; Matthias Seiwerts; Michael Moche; Nikita Garnov; Toni Franz; Minh Do; Jens-Uwe Stolzenburg; Lars-Christian Horn; Thomas Kahn; Harald Busse
Journal:  Eur Radiol       Date:  2012-04-17       Impact factor: 5.315

8.  The "PROCAINA (PROstate CAncer INdication Attitudes) Project" (Part II)--a survey among Italian radiation oncologists on radical radiotherapy in prostate cancer.

Authors:  Berardino De Bari; Filippo Alongi; Pierfrancesco Franco; Patrizia Ciammella; Tarik Chekrine; Lorenzo Livi; Barbara A Jereczek-Fossa; Andrea Riccardo Filippi
Journal:  Radiol Med       Date:  2013-05-27       Impact factor: 3.469

Review 9.  The role of metabolic imaging in radiation therapy of prostate cancer.

Authors:  V Y Zhang; A Westphalen; L Delos Santos; Z L Tabatabai; K Shinohara; D B Vigneron; J Kurhanewicz
Journal:  NMR Biomed       Date:  2013-08-12       Impact factor: 4.044

10.  Anatomic segmentation improves prostate cancer detection with artificial neural networks analysis of 1H magnetic resonance spectroscopic imaging.

Authors:  Lukasz Matulewicz; Jacobus F A Jansen; Louisa Bokacheva; Hebert Alberto Vargas; Oguz Akin; Samson W Fine; Amita Shukla-Dave; James A Eastham; Hedvig Hricak; Jason A Koutcher; Kristen L Zakian
Journal:  J Magn Reson Imaging       Date:  2013-11-15       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.